Literature DB >> 25041985

Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: relevance to neuropsychiatric disorders.

Marcos Leite Santoro1, Camila Maurício Santos2, Vanessa Kiyomi Ota1, Ary Gadelha2, Roberta Sessa Stilhano3, Mariana Cepollaro Diana4, Patrícia Natália Silva5, Letícia Maria Nery Spíndola6, Maria Isabel Melaragno6, Rodrigo Affonseca Bressan2, Sang Won Han3, Vanessa Costhek Abílio4, Sintia Iole Belangero7.   

Abstract

The spontaneously hypertensive rat (SHR) strain was shown to be a useful animal model to study several behavioral, pathophysiological and pharmacological aspects of schizophrenia and attention-deficit/hyperactivity disorder. To further understand the genetic underpinnings of this model, our primary goal in this study was to compare the gene expression profile of neurotransmitter receptors and regulators in the prefrontal cortex (PFC) and nucleus accumbens (NAcc) of SHR and Wistar rats (control group). In addition, we investigated DNA methylation pattern of promoter region of the genes differentially expressed. We performed gene expression analysis using a PCRarray technology, which simultaneously measures the expression of 84 genes related to neurotransmission. Four genes were significantly downregulated in the PFC of SHR compared to Wistar rats (Gad2, Chrnb4, Slc5a7, and Qrfpr) and none in nucleus accumbens. Gad2 and Qrfpr have CpG islands in their promoter region. For both, the promoter region was hypomethylated in SHR group, and probably this mechanism is not related with the downregulation of these genes. In summary, we identified genes that are downregulated in the PFC of SHR, and might be related to the behavioral abnormalities exhibited by this strain.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chrnb4; DNA methylation; Gad2; Gene expression; Qrfpr; Slc5a7; Spontaneously hypertensive rats

Mesh:

Substances:

Year:  2014        PMID: 25041985     DOI: 10.1016/j.psychres.2014.05.034

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield.

Authors:  S Anazi; S Maddirevula; E Faqeih; H Alsedairy; F Alzahrani; H E Shamseldin; N Patel; M Hashem; N Ibrahim; F Abdulwahab; N Ewida; H S Alsaif; H Al Sharif; W Alamoudi; A Kentab; F A Bashiri; M Alnaser; A H AlWadei; M Alfadhel; W Eyaid; A Hashem; A Al Asmari; M M Saleh; A AlSaman; K A Alhasan; M Alsughayir; M Al Shammari; A Mahmoud; Z N Al-Hassnan; M Al-Husain; R Osama Khalil; N Abd El Meguid; A Masri; R Ali; T Ben-Omran; P El Fishway; A Hashish; A Ercan Sencicek; M State; A M Alazami; M A Salih; N Altassan; S T Arold; M Abouelhoda; S M Wakil; D Monies; R Shaheen; F S Alkuraya
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

2.  Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

Authors:  Mariana C Diana; Fernanda F Peres; Veronica Justi; Rodrigo A Bressan; Acioly L T Lacerda; José Alexandre Crippa; Jaime E C Hallak; Vanesssa Costhek Abilio
Journal:  CNS Neurosci Ther       Date:  2018-04-14       Impact factor: 5.243

3.  The variations in human orphan G protein-coupled receptor QRFPR affect PI3K-AKT-mTOR signaling.

Authors:  Huanzheng Li; Ran Lou; Xueqin Xu; Chenyang Xu; Yuan Yu; Yunzhi Xu; Lin Hu; Yanbao Xiang; Xuan Lin; Shaohua Tang
Journal:  J Clin Lab Anal       Date:  2021-05-21       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.